Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
基于网络的疼痛应对技能培训,以改善乳腺癌幸存者芳香酶抑制剂相关关节痛引起的疼痛和依从性差(SKIP-关节痛):一项随机对照试验
基本信息
- 批准号:10630101
- 负责人:
- 金额:$ 62.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAdverse effectsAffectAftercareAlgorithmsAromatase InhibitorsArthralgiaBehavior TherapyBehavioralBreast Cancer survivorCaringCessation of lifeClinicalCognitiveCognitive TherapyCommunitiesContralateral BreastCoping SkillsDatabasesDegenerative polyarthritisDistressEducational process of instructingExerciseFeedbackFutureGeographic LocationsGuidelinesHealthHot flushesInternetInterventionInterviewKnee OsteoarthritisKnowledgeLinkMalignant NeoplasmsMeasuresMediatingMedicalMethodsMinorityNight SweatingOnline SystemsPainPain interferencePain managementParticipantPatient Self-ReportPatient-Focused OutcomesPatientsPersonal SatisfactionPersonsPhysical FunctionPostmenopauseRandomizedRandomized, Controlled TrialsRecurrent Malignant NeoplasmRelaxationReportingResearchResourcesRisk ReductionSelf EfficacySeveritiesSiteSleepSleep DisordersSleep disturbancesStructureSurvivorsSymptomsTelephoneTestingTherapeuticToxic effectTrainingTraining ProgramsTravelWomancancer paincancer recurrencechronic musculoskeletal painclinical carecognitive reappraisalcontactincostdesigndisabilityemotional distressevidence baseexperiencehealth related quality of lifehormone receptor-positiveimprovedinhibitor therapyinnovationjoint stiffnessknee painmalignant breast neoplasmnon-drugnovelnovel strategiespain catastrophizingpain reductionpost interventionprimary endpointprimary outcomeprogramsrural areasecondary outcomeside effectskillsskills trainingsymposiumtherapy developmenttherapy durationtreatment as usualtumorvasomotor symptoms
项目摘要
Aromatase inhibitors (AIs) are standard post-treatment care for postmenopausal breast cancer survivors (BCS)
with hormone-receptor positive (HR+) tumors. AIs improve survival and reduce risk for cancer recurrence, but
they also cause significant adverse effects. The most common is arthralgia—joint pain and stiffness that affects
about 50% of BCS beginning soon after starting an AI. Painful arthralgia causes emotional distress and poor
health-related quality of life (HRQoL). It is also the AI side effect most strongly linked to AI adherence problems,
which are a critical medical concern. Current medical and behavioral interventions for managing painful arthralgia
help only a minority of BCS, cause toxicities that limit their use, or have weak evidence, revealing a critical gap
limiting ability to reduce the impact of painful arthralgia on BCS using AIs. We propose to fill this critical gap with
Pain Coping Skills Training (PCST), a cognitive-behavioral therapy (CBT)-informed intervention. To our
knowledge, no study has evaluated PCST for management of AI-associated painful arthralgia, although
randomized controlled trials (RCTs) show that PCST and similar interventions delivered by trained therapists
can improve pain and reduce disability in people with cancer, chronic musculoskeletal pain, and other pain
conditions. Despite efficacy, PCST continues to be underused in clinical care due to barriers such as high
resource costs, lack of availability in some geographic areas, travel requirements for patients, and a shortage of
trained therapists. We developed a web-based PCST program called painTRAINER to overcome these barriers,
using a novel approach to optimize engagement and retain therapeutically critical features of therapist-delivered
PCST in an “automated” program that does not require therapist involvement. PainTRAINER mimics highly
interactive and personalized therapist-delivered PCST. RCT evidence shows that painTRAINER is highly
acceptable and engaging, and that it can reduce joint pain and stiffness in people with osteoarthritis (OA). We
now seek to evaluate whether it can improve the severity of painful arthralgia and its associated interference and
other adverse impacts on BCS on AI therapy. The proposed multi-site RCT will randomize 452 BCS with AI-
associated painful arthralgia to enhanced usual care (EUC) or painTRAINER+EUC. Assessments will occur at
baseline, post-intervention (12 weeks after baseline), and 3- and 6-months post-intervention. Aims are to
determine whether painTRAINER+EUC, compared to EUC, improves pain severity and pain interference (Aim
1, primary outcomes) as well as distress, HRQoL, and AI adherence (Aim 2, secondary outcomes). We will also
determine whether these effects on primary and secondary outcomes are at least partially mediated by increases
in pain self-efficacy and reductions in pain catastrophizing (Aim 3). Finally, for an exploratory aim we will evaluate
beneficial indirect effects on sleep problems and vasomotor symptoms in addition to gathering participant
feedback on painTRAINER’s fit for their unique needs. This RCT could yield a highly disseminable intervention
that could be quickly implemented clinically, including in geographic areas with limited access to PCST.
芳香酶抑制剂(Ais)是绝经后乳腺癌幸存者(Bcs)的标准治疗后护理。
激素受体阳性(HR+)肿瘤。人工智能可提高存活率,降低癌症复发风险,但
它们还会造成严重的不利影响。最常见的是关节痛--影响关节的疼痛和僵硬
大约50%的BCS在开始人工智能后不久开始。痛性关节痛会导致情绪困扰和贫穷
健康相关生活质量(HRQOL)。这也是与人工智能坚持问题联系最紧密的人工智能副作用,
这是一个严重的医疗问题。治疗痛性关节痛的现代医学和行为干预
只帮助一小部分BCS,导致限制其使用的毒性,或者证据薄弱,暴露出严重的差距
使用AIS减少疼痛关节痛对BCS的影响的能力有限。我们建议用以下方式填补这一关键空白
疼痛应对技能培训(PCST),一种认知行为疗法(CBT)知情的干预。致我们的
知识,还没有研究评估PCST治疗AI相关的疼痛关节痛,尽管
随机对照试验(RCT)显示,PCST和类似的干预措施由训练有素的治疗师提供
可以改善癌症、慢性肌肉骨骼疼痛和其他疼痛患者的疼痛并减少残疾
条件。尽管有效,但PCST在临床护理中仍未得到充分利用,原因是
资源成本、一些地理区域缺乏可获得性、患者的旅行要求以及缺乏
训练有素的心理医生。我们开发了一个基于网络的PCST程序,名为PainTRAINER来克服这些障碍,
使用一种新方法来优化参与度并保留治疗师提供的治疗关键特征
PCST是一种“自动”程序,不需要治疗师的参与。PainTRAINER高度模仿
互动和个性化治疗师提供的PCST。RCT证据显示PainTRAINER对
它是可接受和吸引人的,它可以减轻骨关节炎(OA)患者的关节疼痛和僵硬。我们
现在寻求评估它是否可以改善疼痛关节痛的严重程度及其相关的干预和
人工智能治疗对BCS的其他不良影响。拟议的多站点随机对照试验将使用人工智能随机选择452个BCS-
与疼痛相关的关节痛与加强日常护理(EUC)或疼痛治疗+EUC有关。评估将在
基线、干预后(基线后12周)、干预后3个月和6个月。目标是
确定与EUC相比,PainTRAINER+EUC是否可以改善疼痛严重程度和疼痛干预(AIM
1,主要结果)以及苦恼、HRQL和AI依从性(目标2,次要结果)。我们还将
确定这些对主要和次要结果的影响是否至少部分地通过增加来调节
在疼痛自我效能感和减少疼痛灾难方面(目标3)。最后,为了探索性的目的,我们将评估
除了聚集参与者外,还对睡眠问题和血管舒缩症状产生有益的间接影响
对PainTRAINER适合他们独特需求的反馈。这种随机对照试验可以产生高度可传播的干预措施。
这可能很快在临床上实施,包括在获得PCST机会有限的地理地区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christine Rini其他文献
Christine Rini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christine Rini', 18)}}的其他基金
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
基于网络的疼痛应对技能培训,以改善乳腺癌幸存者芳香酶抑制剂相关关节痛引起的疼痛和依从性差(SKIP-关节痛):一项随机对照试验
- 批准号:
10439192 - 财政年份:2022
- 资助金额:
$ 62.88万 - 项目类别:
Giving and receiving: A reciprocal support writing intervention to reduce symptoms during stem cell transplant
给予和接受:相互支持写作干预,以减轻干细胞移植期间的症状
- 批准号:
10083520 - 财政年份:2018
- 资助金额:
$ 62.88万 - 项目类别:
Giving and receiving: A reciprocal support writing intervention to reduce symptoms during stem cell transplant
给予和接受:相互支持写作干预,以减轻干细胞移植期间的症状
- 批准号:
10197839 - 财政年份:2018
- 资助金额:
$ 62.88万 - 项目类别:
Giving and receiving: A reciprocal support writing intervention to reduce symptoms during stem cell transplant
给予和接受:相互支持写作干预,以减轻干细胞移植期间的症状
- 批准号:
9750307 - 财政年份:2018
- 资助金额:
$ 62.88万 - 项目类别:
Clarifying critical processes linking partner support to insufficiently active
澄清将合作伙伴支持与不够活跃联系起来的关键流程
- 批准号:
8472894 - 财政年份:2013
- 资助金额:
$ 62.88万 - 项目类别:
Internet-based osteoarthritis pain coping skills intervention
基于互联网的骨关节炎疼痛应对技能干预
- 批准号:
8038889 - 财政年份:2010
- 资助金额:
$ 62.88万 - 项目类别:
Internet-based osteoarthritis pain coping skills intervention
基于互联网的骨关节炎疼痛应对技能干预
- 批准号:
8146207 - 财政年份:2010
- 资助金额:
$ 62.88万 - 项目类别:
Internet-based osteoarthritis pain coping skills intervention
基于互联网的骨关节炎疼痛应对技能干预
- 批准号:
8287659 - 财政年份:2010
- 资助金额:
$ 62.88万 - 项目类别:
Predicting Surgical Decisions of High-Risk UC Patients
预测高危 UC 患者的手术决策
- 批准号:
7273676 - 财政年份:2005
- 资助金额:
$ 62.88万 - 项目类别:
Predicting Surgical Decisions of High-Risk UC Patients
预测高危 UC 患者的手术决策
- 批准号:
7114341 - 财政年份:2005
- 资助金额:
$ 62.88万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 62.88万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 62.88万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 62.88万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 62.88万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 62.88万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 62.88万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 62.88万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 62.88万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 62.88万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 62.88万 - 项目类别:
Fellowship Programs